View Alert


Originator: CAS - Helpdesk - Team

From: Helpdesk Team

Issue date: 04-Mar-2021 13:04:13

This alert has been issued to:
  • Care Trusts
  • Mental Health Trusts
  • MHRA (Medicines) Drug Alerts (Various Recipients)
  • Other contacts
  • Specialists Trusts
  • Independent Healthcare Providers (registered with CAS)
  • Clinical Commissioning Groups
  • NHS Regional Offices
  • Learning Disabilities Trusts
  • Mental Health & Social Care Trusts
  • NHS Foundation Trusts (England) - Medical Director
  • NHS Foundation Trusts (England) - Chief Executive
  • Ofsted recipients
  • Ambulance Trusts
  • Social Care Providers (registered with CAS)
  • Special Health Authorities
  • NHS Trusts (England) - Medical Director
  • CMO Urgent Messages - Non-NHS Recipients on Public Health Link
  • MHRA (Medicines) Drug Alerts - Non-NHS Recipients
  • Mental Health & Learning Disabilities
  • Territorial CMOs in Northern Ireland, Scotland & Wales
  • Regional Directors of Public Health
  • Consultants in Communicable Diseases
  • CMO Urgent Messages - Recipients on Public Health Link
  • Director of Public Health
  • Acute Trusts
  • Community Trusts
  • NHS Trusts (England) - Chief Executive
  • GP - Locum
  • NHS 111 and Out of hours providers
  • Dispensing GP Practices
  • GP Practices
  • DHSC Supply Disruption - Medicines
  • Out of hours contacts
  • Community Pharmacy
  • Primary Care Networks
  • GP Practices 1

Action category: Action

Title: Changes to MHRA Drug Alert titles and classifications

Broadcast content:
The attached provides further information regarding MHRA Defective Medicines Report Centre safety messaging. This replaces CH/2021/001 which was published on 02 February 2021.



Additional information: NHS England and NHS Improvement Regional Offices: please cascade this message to Community Pharmacy, Dental and Optometry contractors.

Alert reference: CH/2021/002

Attachments:

Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency